Harold King
National Institute for Medical Research
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Harold King.
Proceedings of the Royal Society of London B: Biological Sciences | 1946
Christopher Howard Andrewes; Harold King; James Walker
The discovery of the pronounced anti-rickettsial activity of p-sulphonamidobenzamidine on experimental typhus infections in mice has led to a search for compounds of enhanced therapeutic action. A large number of compounds have been prepared in development of the sulphonamido-amidine structure, but anti-rickettsial activity has been found to be confined to about a dozen substances intimately related to p-sulphonamidobenzamidine, only one, namely, p-sulphonamidobenzamidoxime, having a very slightly superior therapeutic action. The significance of the discovery of yet another sulphonamide type with pronounced biological activity is discussed.
Proceedings of the Royal Society of London. Series B, Biological sciences | 1950
J. D. Fulton; L. P. Joyner; Harold King; J. M. Osbond; Jean Wright
This communication describes some of the results which have been obtained in the search for an amoebicidal agent which might replace emetine. Eighty-seven compounds have been synthesized starting from two 4-chloroquinolines with a methyl or anilino group in the 2-position. A number of compounds have been found with an in vitro activity on Entamoeba histolytica slightly inferior to that of emetine.
Proceedings of the Royal Society of London B: Biological Sciences | 1948
Harold King; Jean Wright
This communication completes this series of investigations. Ten carbinolamines derived from 6:7-dimethylquinoline and based on the quinine model are described. Three of the substances containing the 2-phenyl-6:7-dimethylquinoline nucleus show antiplasmodial activity on malaria in canaries much superior to the activity of quinine. The 6:7-dimethyi groups present in these compounds show a structural affinity with riboflavin but the antiplasmodial results are not favourable to the view that riboflavin-antagonism plays any significant part in the mechanism of action of these active bases.
Proceedings of the Royal Society of London B: Biological Sciences | 1938
A. D. Ainley; Harold King
Biochemical Journal | 1927
Winston Kennay Anslow; Harold King
Proceedings of the Royal Society of London B: Biological Sciences | 1938
Arthur Cohen; Harold King
Journal of Chemical Technology & Biotechnology | 1935
O. Rosenheim; Harold King
Biochemical Journal | 1929
Harold King; Otto Rosenheim; Thomas Arthur Webster
British journal of pharmacology and chemotherapy | 1946
C.H. Andrewes; Harold King; James Walker
British Medical Bulletin | 1946
C. H. Andrewes; Harold King